GlassScriptPhysician profile
Jordan Michael Glaser
NPI 1194058404
$14,065.50
in general payments reported to CMS, 2019-2025
14 companies · $9,256 in 2025
The $9,256 reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2020: $89.44 · 2021: $162 · 2022: $1,702 · 2023: $583 · 2024: $1,774 · 2025: $9,256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,000 · Travel and Lodging: $4,577 · Food and Beverage: $1,797 · Education: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,000.00 |
| Travel and Lodging | $4,577.49 |
| Food and Beverage | $1,797.35 |
| Education | $238.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $6,787.34 | 2020-2025 | Evos |
| Stryker Corporation | $4,275.37 | 2019-2025 | Pro, Pelvis II, Es2 Spinal System |
| Arthrex, INC. | $1,460.05 | 2024 | |
| Tricoast Surgical Solutions LLC | $883.87 | 2023-2024 | |
| Globus Medical, INC. | $116.61 | 2019-2025 | Anthem |
| Medtronic, INC. | $109.57 | 2021 | |
| Depuy Synthes Sales INC. | $100.86 | 2019 | |
| Medtronic USA, INC. | $91.71 | 2019 | |
| Pacira Therapeutics, INC. | $76.34 | 2020-2021 | |
| Blue Surgical LLC | $57.44 | 2025 | |
| Zimmer Biomet Holdings, INC. | $37.25 | 2020 | |
| Si-Bone, INC. | $28.83 | 2022 | |
| Neuros Medical, INC. | $25.81 | 2025 | Altius |
| Radius Health, INC. | $14.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Glaser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.